CPT 0888T: Focused Ultrasound Ablation of Renal (Kidney) Tumor

CPT code 0888T designates image-guided focused ultrasound ablation of cancerous renal (kidney) tissue using a specialized device. This minimally invasive, non-incisional technique is focused on destroying malignant renal tumors while preserving surrounding tissue. Nationally, the code represents an emerging therapeutic option that intersects oncology, interventional radiology, and surgical oncology and is relevant for hospitals, ambulatory surgery centers, and payers evaluating coverage and utilization for novel ablation therapies.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of clinical context and service delivery, typical sites of service, common billing modifiers and administrative considerations (listed elsewhere), and a summary of what to expect in payer engagement. The publication outlines benchmarks for adoption and reimbursement landscape where available, policy update implications for coverage determination, and operational considerations for coding and claims submission.

This summary is intended to provide clinicians, billing professionals, and policy stakeholders with an overview of what CPT code 0888T represents, why it matters in the evolving field of renal tumor management, and the types of resources and analyses included in the full publication. Data not available in the input is noted where applicable in detailed sections.

Billing Code Overview

CPT code 0888T describes a procedure in which a provider delivers focused ultrasound energy into the body using a specialized device to ablate cancerous renal (kidney) tissue under image guidance. The procedure is a form of image-guided tumor ablation performed to destroy malignant renal tissue while minimizing damage to surrounding structures.

Service type: Image-guided focused ultrasound ablation of renal (kidney) tumor
Typical site of service: Hospital outpatient department or ambulatory surgical center with image-guidance capabilities

Clinical Context

A typical patient is a 65-year-old with a solitary, biopsy-proven renal cell carcinoma (RCC) in a single kidney or a small renal mass in a patient at increased surgical risk due to comorbidities (cardiopulmonary disease, anticoagulation, or prior abdominal surgery). The patient presents with imaging surveillance demonstrating a 2–4 cm enhancing renal cortical mass suspicious for malignancy. Pre-procedure workup includes cross-sectional imaging (CT or MRI) to localize the lesion, laboratory testing (coagulation panel, basic metabolic panel), and a pre-anesthesia evaluation.

The clinical workflow: the interventional radiologist or urologist performs pre-procedure planning with image review and discusses risks/benefits with the patient. On the day of service the patient is brought to an outpatient procedure suite or hospital operating room depending on anesthesia needs. Under conscious sedation or general anesthesia, percutaneous (or laparoscopic) placement of a specialized ultrasound energy delivery device into the renal tumor is performed using real-time image guidance (ultrasound and/or CT). The device delivers focused ultrasound energy to ablate tumor tissue while the operator monitors ablation extent and surrounding structures. Post-procedure, the patient is observed in recovery, has post-procedure imaging or immediate ultrasound/CT to evaluate for complications, and receives discharge instructions or inpatient admission if clinically indicated.

Coding Specifications

Modifier	Description	When to Use
`22`

Taxonomy Code	Specialty	Notes
2086S0200X	Interventional Radiology	Most common specialty performing percutaneous renal ablation using image guidance.
2080P0201X	Urology	Urologists may perform laparoscopic or percutaneous ablative procedures for renal tumors.
363L00000X	Surgical Oncology	Surgical oncologists may be involved for complex tumor management and multidisciplinary cases.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C64.1`	Malignant neoplasm of right kidney, except renal pelvis	Primary indication for focal renal tumor ablation on the right side.
`C64.2`	Malignant neoplasm of left kidney, except renal pelvis	Primary indication for focal renal tumor ablation on the left side.
`D41.4`	Neoplasm of uncertain behavior of kidney	Used when lesion behavior is indeterminate and ablation is considered for diagnostic/therapeutic management.
`N28.9`	Disorder of kidney and ureter, unspecified	May be used for non-specific renal lesions when more specific diagnosis is pending.
`Z90.11`	Acquired absence of right kidney (renal)	Relevant when treating a solitary left kidney patient or vice versa; procedural planning differs for solitary kidney.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`76942`	Ultrasonic guidance for needle placement (e.g., biopsy, aspiration, injection, localization device), imaging supervision and interpretation	Used for real-time ultrasound guidance during percutaneous device placement into the renal lesion.
`77012`	CT guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation	Used when CT guidance is utilized for device placement or to monitor ablation.
`76930`	Magnetic resonance guidance for needle placement, imaging supervision and interpretation	Used if MR guidance is employed for targeting or monitoring the ablation.
`51728`	Placement of ureteral stent, with or without cystoscopy (if needed)	May be performed pre- or post-ablation if urinary drainage or decompression is required.
`90901`	Application of focused ultrasound therapy (example—procedure code placeholder for related thermal ablation services)	Represents related thermal ablation services and context for billing and crosswalks; used in workflow when other ablation codes are applicable.

OpenPayer

Summary & Overview